Cambridge Healthtech Institute’s 18th Annual
Optimising Expression Platforms
Employing Cell Factories for the Enhanced Production of Recombinant Proteins
12 November 2025
The growing use of recombinant proteins for research in structure, targets, and therapeutics demands efficient expression and production strategies that balance yield, quality, time, and cost. With no universal system ensuring high yields, selecting the optimal host requires a deep understanding of the desired protein’s characteristics as every protein itself causes its own expression and production concerns. At PEGS Europe, Cambridge Healthtech Institute’s 18th Annual Optimising Expression Platforms conference explores case studies comparing and evaluating expression systems, highlighting strategies to match proteins with the right hosts and overcoming production challenges. Join leading scientists as they share solutions to enhance protein expression efficiency and streamline biotherapeutic and research applications.
Coverage will include, but is not limited to:
- Biotherapeutics
- Antibodies
- Recombinant Proteins
- “Designer” Proteins
- Miniproteins
- Peptides
- Vaccines
- Difficult-to-Express Proteins
- VLPs
- Viral Vectors
- Membrane Proteins
- Enzymes
- Toxic Proteins
- Cell Factories
- Mammalian
- Insect
- Bacterial
- Yeast
- Other
- Cell Line Engineering
- Matching Host to Protein of Choice
- Re‐Engineering Existing Systems for Better Performance
- Automation for Higher Throughput
- Faster Turnaround Times
- Increasing Speed and Lowering Cost
- Case Studies
The deadline for priority consideration is 28 March 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: